Evidence map›Paper›PMID 16369490›Full record

ArticleOncogene2006

Cellular ITAM-containing proteins are oncoproteins in nonhematopoietic cells.

S M Grande, E Katz, J E Crowley, M S Bernardini, S R Ross, J G Monroe

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

S M GrandeDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
E Katz
J E Crowley
M S Bernardini
S R Ross
J G Monroe
University of Pennsylvania · US

Funding

The Function of Tribbles in the Pathogenesis of AMLP01CA093615 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BURKHARDT, JANIS K. · 2002 to 2011
$16.2M
IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTEST32CA009140 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Malay Haldar, WARREN S PEAR · 1985 to 2026
$16.1M
REGULATED B-CELL UNRESPONSIVENESS AND TOLERANCER01AI032592 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CHOI, YONGWON · 1993 to 2011
$3.9M
NCI NIH HHS CA09140NCI NIH HHS P01-CA093615NIAID NIH HHS R01-AI32592NIAID NIH HHS R01-AI43620
6 · The paper itself

Abstract

Immunoreceptor tyrosine-based activation motifs (ITAMs) are involved in the transduction of signals necessary for activation, differentiation, and survival in hematopoietic cells. Several viruses have been shown to encode ITAM-containing transmembrane proteins. Although expression of these viral proteins has in some cases been shown to transform nonhematopoietic cells, a causal role for a functional ITAM in this process has not been elucidated. To examine the potential transforming properties of ITAM-containing proteins, a recombinant protein consisting of ITAM-containing cytoplasmic regions of the B-cell antigen receptor was expressed in immortalized murine mammary epithelial and fibroblast cells. Mammary epithelial cells expressing this construct exhibited depolarized morphology in three-dimensional cultures. This transformed phenotype was characterized by a loss of anchorage dependence and hallmarks of epithelial to mesenchymal transition. Fibroblasts expressing this ITAM construct also lost contact inhibition and anchorage dependence. The transformed phenotype seen in both cell types was abrogated upon tyrosine to phenylalanine substitutions of the ITAMs. Inhibition of Syk tyrosine kinase, which associates with the ITAM, also prevented cell transformation. Our results indicate that expression of a nonviral ITAM-containing protein is sufficient for cell transformation. Despite lacking intrinsic enzymatic activity, ITAM-containing proteins can function as potent oncoproteins by scaffolding downstream mediators.

Indexed as

Amino Acid MotifsAmino Acid SubstitutionAnimalsCell Transformation, NeoplasticColony-Forming Units AssayEpithelial CellsFemaleFibroblastsFlow CytometryFluorescent Antibody TechniqueImmunoprecipitationIntracellular Signaling Peptides and ProteinsMaleMammary Glands, AnimalMiceNIH 3T3 CellsIntracellular Signaling Peptides and ProteinsOncogene ProteinsPhenylalanineProtein-Tyrosine KinasesReceptors, Antigen, B-Cellsrc-Family KinasesSyk KinaseSyk protein, mouseTyrosine

Identifiers

PMID16369490
OpenAlexW2054624034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.